ALRISE Biosystems

Advancing drug delivery through precision micro-encapsulation and long-acting injectables.

ALRISE Biosystems is a drug delivery company focused on advanced micro encapsulation of pharmaceutically active ingredients. ALRISE's core business includes the development of long-acting injectable depot products for controlled release applications. ALRISE is winner of the 2014 Frost & Sullivan Drug Delivery Technology Innovation Leadership Award. Exit: 2021 Asset purchase by Ferring International Center S.A. Exit: 2021 Asset purchase by Ferring International Center S.A.
investment manager
invested since
2006
website